PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PanGenomic Health, Inc. has announced an anticipated delay in filing its 2023 financial statements, with a new expected filing date set on or before June 28, 2024, due to payment delays to its auditors. The British Columbia Securities Commission has issued a management cease trade order that restricts company executives from trading securities, but does not hinder shareholder trading. The company is following NP 12-203 guidelines and will continue to provide bi-weekly status updates.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.